Search Results - Elisabetta Cretella
- Showing 1 - 14 results of 14
-
1
Maxillary Response Induced by Rapid Palatal Expansion vs. Clear Aligners: A Short-Term Retrospective Evaluation of the Dento-Alveolar Effects in Mixed Dentition by Elisabetta Cretella Lombardo, Silvia Fanelli, Chiara Pavoni, Paola Cozza, Roberta Lione
Published in Applied Sciences (2023-07-01)Get full text
Article -
2
-
3
-
4
Evaluation of the Upper Arch Morphological Changes after Two Different Protocols of Expansion in Early Mixed Dentition: Rapid Maxillary Expansion and Invisalign<sup>®</sup> First S... by Elisabetta Cretella Lombardo, Valeria Paoloni, Silvia Fanelli, Chiara Pavoni, Francesca Gazzani, Paola Cozza
Published in Life (2022-08-01)Get full text
Article -
5
Comparison between twin block appliance and mandibular advancement on clear aligners in the improvement of airway dimension: incremental versus maximum bite advancement by Elisabetta Cretella Lombardo, Letizia Lugli, Paola Cozza, Roberta Lione, Saveria Loberto, Chiara Pavoni
Published in Frontiers in Oral Health (2024-09-01)Get full text
Article -
6
Role of yUbp8 in Mitochondria and Hypoxia Entangles the Finding of Human Ortholog Usp22 in the Glioblastoma Pseudo-Palisade Microlayer by Veronica De Luca, Manuela Leo, Elisabetta Cretella, Arianna Montanari, Michele Saliola, Gabriele Ciaffi, Andrea Vecchione, Antonella Stoppacciaro, Patrizia Filetici
Published in Cells (2022-05-01)Get full text
Article -
7
Prevalence of tooth decay in deciduous and permanent teeth in a schoolchildren population: an epidemiological investigation by Silvia Fanelli, Letizia Lugli, Francesca Chiara De Razza, Francesca Gazzani, Saveria Loberto, Elisabetta Cretella Lombardo, Francesco Fabi, Arianna Malara
Published in Annali di Stomatologia (2024-04-01)Get full text
Article -
8
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or... by Benedetta Pellegrino, Luisa Carbognin, Emilio Bria, Alberto Zambelli, Filippo Montemurro, Elena Fiorio, Claudio Zamagni, Nicoletta Campanini, Michele Tognetto, Gabriele Missale, Antonino Musolino, Stefania Gori, Giuseppe Maglietta, Chiara Tommasi, Olga Serra, Elisabetta Cretella, Massimo Ambroggi, Antonio Frassoldati, Giancarlo Bisagni, Chiara Casarini, Antonella Mura, Lorenzo Gianni, Renata Todeschini, Enrico Maria Silini
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Get full text
Article -
9
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study by Agnese Fabbri, Fabrizio Nelli, Andrea Botticelli, Diana Giannarelli, Eleonora Marrucci, Cristina Fiore, Antonella Virtuoso, Simone Scagnoli, Simona Pisegna, Daniele Alesini, Valentina Sini, Armando Orlandi, Alessandra Fabi, Federico Piacentini, Luca Moscetti, Giuliana D’Auria, Teresa Gamucci, Marco Mazzotta, Laura Pizzuti, Patrizia Vici, Elisabetta Cretella, Paola Scavina, Annalisa La Cesa, Mara Persano, Francesco Atzori, Enzo Maria Ruggeri
Published in Frontiers in Oncology (2023-06-01)Get full text
Article -
10
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer by Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi
Published in Breast (2024-10-01)Get full text
Article -
11
RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer by Alba Llop-Guevara, Benedetta Pellegrino, Isabel Pimentel, Guillermo Villacampa, Cinzia Solinas, Sara Torres-Esquius, Nicoletta Campanini, Sara Simonetti, Chiara Tommasi, Olga Serra, Matilde Corianò, Daniela Boggiani, Maria Michiara, Roberta Minari, Beatrice Bortesi, Elena Rapacchi, Maria Vittoria Dieci, Matteo Lambertini, Gabriele Zoppoli, Alessio Schirone, Chiara Casarini, Elisabetta Cretella, Laura Cortesi, Enrico Maria Silini, Cristina Saura, Karen Willard-Gallo, Anais Boisson, Antonino Musolino, Violeta Serra, Judith Balmaña, Cristina Cruz
Published in npj Breast Cancer (2026-03-01)Get full text
Article -
12
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical... by Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Piermario Salvini, Gianluigi Ferretti, Elisabetta Cretella, Lorenzo Gianni, Claudia Bighin, Angela Toss, Angela Toss, Claudio Zamagni, Patrizia Vici, Costanza De Rossi, Antonio Russo, Giancarlo Bisagni, Alessio Schirone, Lucia Borgato, Anna Cariello, Claudia Cappelletti, Roberto Bordonaro, Saverio Cinieri, Alessandra Modena, Matteo Valerio, Maria Francesca Alvisi, Irene De Simone, Francesca Galli, Eliana Rulli, Anna Santoni, Matteo Verzè, Fabrizio Nicolis
Published in Frontiers in Oncology (2025-04-01)Get full text
Article -
13
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. by Stefania Gori, Alessandro Inno, Elena Fiorio, Jennifer Foglietta, Antonella Ferro, Marcella Gulisano, Graziella Pinotti, Marta Gubiotti, Maria Giovanna Cavazzini, Monica Turazza, Simona Duranti, Valeria De Simone, Laura Iezzi, Giancarlo Bisagni, Simon Spazzapan, Luigi Cavanna, Chiara Saggia, Emilio Bria, Elisabetta Cretella, Patrizia Vici, Daniele Santini, Alessandra Fabi, Ornella Garrone, Antonio Frassoldati, Laura Amaducci, Silvana Saracchini, Lucia Evangelisti, Sandro Barni, Teresa Gamucci, Lucia Mentuccia, Lucio Laudadio, Alessandra Zoboli, Fabiana Marchetti, Giuseppe Bogina, Gianluigi Lunardi, Luca Boni
Published in PLoS ONE (2015-01-01)Get full text
Article -
14
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors by Roberta Scafetta, Marco Donato, Carla Gullotta, Alessandra Guarino, Cristina Fiore, Luisana Sisca, Elena Speziale, Raffaella Troiano, Simone Foderaro, Valentina Ricozzi, Michele Iuliani, Sonia Simonetti, Silvia Cavaliere, Alessio Cortellini, Andrea Botticelli, Simone Scagnoli, Simona Pisegna, Carmen Criscitiello, Rebecca Pedersini, Caterina Sposetti, Elisa Tiberi, Giuliana D'Auria, Matteo Vergati, Marco Mazzotta, Roberta Caputo, Annarita Verrazzo, Maria Grazia Rossino, Federica Domati, Claudia Piombino, Francesca Sofia Di Lisa, Lorena Filomeno, Teresa Arcuri, Federica Puce, Federica Riva, Michela Palleschi, Marianna Sirico, Marta Piras, Luigia Stefania Stucci, Delia De Lisi, Paolo Orsaria, Edy Ippolito, Sara Ramella, Luca Visani, Niccolò Bertini, Ilaria Bonaparte, Stefania Gori, Luigi Rossi, Icro Meattini, Barbara Tagliaferri, Orazio Caffo, Ilaria Portarena, Azzurra Irelli, Elisabetta Cretella, Camillo Porta, Giampaolo Bianchini, Agnese Fabbri, Ugo De Giorgi, Patrizia Vici, Angela Toss, Ornella Garrone, Michelino De Laurentiis, Federica Villa, Rossana Berardi, Mauro Minelli, Claudio Vernieri, Giuseppe Curigliano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Published in Breast (2025-08-01)Get full text
Article
